Highbridge Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-36,562
| Closed | -$170K | – | 1435 |
|
|
2016
Q1 | $170K | Buy |
36,562
+24,012
| +191% | +$112K | ﹤0.01% | 732 |
|
|
2015
Q4 | $63K | Buy |
+12,550
| New | +$63K | ﹤0.01% | 779 |
|
|
2015
Q3 | – | Sell |
-79,303
| Closed | -$791K | – | 1244 |
|
|
2015
Q2 | $791K | Buy |
+79,303
| New | +$791K | 0.01% | 522 |
|
|
2014
Q3 | – | Sell |
-21,505
| Closed | -$331K | – | 1089 |
|
|
2014
Q2 | $331K | Buy |
+21,505
| New | +$331K | ﹤0.01% | 583 |
|
|
2013
Q4 | – | Sell |
-42,201
| Closed | -$426K | – | 1072 |
|
|
2013
Q3 | $426K | Buy |
+42,201
| New | +$426K | ﹤0.01% | 705 |
|